CSPC PHARMA (01093): CSPC Innovation Pharmaceutical (300765.SZ) reported a net profit attributable to shareholders of approximately 1.261 billion yuan in the first half of the year, turning losses into profits year-on-year.
Shiyao Group (01093) announced the mid-term performance of Shiyao Innovation (300765.SZ) for 2026, with operating revenue of approximately 3.24 billion yuan, a year-on-year increase of 208.72%; the net profit attributable to shareholders of the listed company was approximately 1.261 billion yuan, turning a loss into a profit year-on-year; basic earnings per share were 0.9056 yuan.
CSPC PHARMA (01093) announced that CSPC Innovation Pharmaceutical (300765.SZ) reported its mid-year performance for 2026, with operating revenue of approximately 3.24 billion yuan, a year-on-year increase of 208.72%; the net profit attributable to shareholders of the listed company was approximately 1.261 billion yuan, turning a profit from a loss compared to the previous year; basic earnings per share were 0.9056 yuan.
Related Articles
China Railway Signal & Communication Corporation (03969) has nominated Lou Qiliang and Dong Baoliang as candidate executive directors.
GOFINTECH QUANT (00290) has completed the placement of a total of 219 million shares and has terminated the old shares first, new shares subscription.
SDHS NEW ENERGY (01250) expects its interim profit attributable to shareholders to be approximately 139 million to about 170 million yuan.
China Railway Signal & Communication Corporation (03969) has nominated Lou Qiliang and Dong Baoliang as candidate executive directors.
GOFINTECH QUANT (00290) has completed the placement of a total of 219 million shares and has terminated the old shares first, new shares subscription.
SDHS NEW ENERGY (01250) expects its interim profit attributable to shareholders to be approximately 139 million to about 170 million yuan.
RECOMMEND
